RVMD compared with TNGX: revenue, margins and what each company keeps, and the suppliers and customers both name

RVMDRevolution Medicines, Inc.

Mkt capRevenueRevenue

TNGXTango Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

RVMDRevolution Medicines, Inc.

TNGXTango Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only RVMD 6

SNYSanoficustomer

RPRXRoyalty Pharma Investments 2019 ICAV (Royalty Pharma)customer

—Aethon Therapeuticsunlistedsupplier

—Continental Stock Transfer & Trustunlistedsupplier

2 more · RVMD chain ›

Shared 0

No shared counterparties.

Only TNGX 1

—WuXi AppTecunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

RVMDRevolution Medicines, Inc.

192.54▲+8.38%· post 193.00

Mkt cap$41.6BRevenue$198MQ3 FY26Revenue—

TNGXTango Therapeutics, Inc.

21.49▲+2.96%· post 21.49

ClosedNov 6 '26

Mkt cap$3.6BRevenue$54MQ3 FY25Revenue$42MFY24

Compare

ClosedNov 6 '26

RVMDRevolution Medicines, Inc.

TNGXTango Therapeutics, Inc.

192.54▲+8.38%post 193.00

Price

21.49▲+2.96%post 21.49

$41.6B

Mkt cap

$3.6B

Q3 FY26$198M

Revenue

$54MQ3 FY25

—

Revenue

$42MFY24

RVMD192.54▲+8.38%vsTNGX21.49▲+2.96%ClosedNov 6 '26